XK
BIIB icon

Xact Kapitalforvaltning’s Biogen BIIB Stock Holding History

Xact Kapitalforvaltning’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$12.8M Sell
40,527
-5,068
-11% -$1.54M 0.27% 71
2019
Q4 		$13.5M Sell
45,595
-3,206
-7% -$890K 0.23% 87
2019
Q3 		$11.4M Buy
48,801
+2,840
+6% +$661K 0.22% 90
2019
Q2 		$10.7M Buy
45,961
+1,524
+3% +$352K 0.22% 87
2019
Q1 		$10.5M Buy
44,437
+7,020
+19% +$2.21M 0.24% 79
2018
Q4 		$11.3M Sell
37,417
-4,448
-11% -$1.42M 0.29% 61
2018
Q3 		$14.8M Sell
41,865
-3,973
-9% -$1.37M 0.31% 56
2018
Q2 		$13.3M Buy
45,838
+657
+1% +$185K 0.28% 61
2018
Q1 		$12.4M Buy
45,181
+1,077
+2% +$334K 0.28% 65
2017
Q4 		$14.1M Buy
44,104
+3,684
+9% +$1.18M 0.34% 58
2017
Q3 		$12.7M Buy
40,420
+143
+0.4% +$42.3K 0.36% 58
2017
Q2 		$10.9M Sell
40,277
-235
-0.6% -$62.1K 0.33% 61
2017
Q1 		$11.1M Buy
40,512
+4,258
+12% +$1.2M 0.34% 62
2016
Q4 		$10.3M Buy
36,254
+2,220
+7% +$658K 0.36% 58
2016
Q3 		$10.7M Buy
+34,034
New +$10.1M 0.38% 57

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Xact Kapitalforvaltning's BIIB Position: Q1 2020 in Review

Xact Kapitalforvaltning reduced its Biogen (BIIB) stake by 11% in Q1 2020, selling an estimated $1.54M and leaving 40,527 shares worth $12.8M. The position accounts for 0.27% of the portfolio, ranked #71.

Xact Kapitalforvaltning first reported a position in BIIB in Q3 2016 and has held it in 15 quarters since. The position peaked at $14.8M in Q3 2018. 1,100 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Xact Kapitalforvaltning held 40,527 shares of Biogen worth $12.8M as of Q1 2020.
  • Xact Kapitalforvaltning sold 5,068 Biogen shares in Q1 2020, an estimated $1.54M.
  • Biogen made up 0.27% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #71 holding.
  • Xact Kapitalforvaltning first reported a position in Biogen in Q3 2016 and has held it in 15 quarters since.
  • Xact Kapitalforvaltning's Biogen position peaked at $14.8M in Q3 2018.
  • 1,100 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.